Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3258681, 11 pages
https://doi.org/10.1155/2017/3258681
Review Article

Current Status and Future Perspective of Stenting for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis

1Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China
2Department of Neurology, China-Japan Friendship Hospital, Beijing 100029, China
3Department of Neurology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
4Department of Radiology, China-Japan Friendship Hospital, Beijing 100029, China

Correspondence should be addressed to Zun-Jing Liu; moc.361@gnijnuzuil

Received 24 February 2017; Revised 10 April 2017; Accepted 7 May 2017; Published 18 June 2017

Academic Editor: Sheng Chen

Copyright © 2017 Zhong-Hao Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Arenillas, “Intracranial atherosclerosis: current concepts,” Stroke, vol. 42, supplement 1, pp. S20–S23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. S. Wong and H. Li, “Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis,” Stroke, vol. 34, no. 10, pp. 2361–2366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. L. Sacco, D. E. Kargman, Q. Gu, and M. C. Zamanillo, “Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan stroke study,” Stroke, vol. 26, no. 1, pp. 14–20, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. K. Suri and S. C. Johnston, “Epidemiology of intracranial stenosis,” Journal of Neuroimaging, vol. 19, no. 1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. K. S. Wong, “Global burden of intracranial atherosclerosis,” International Journal of Stroke, vol. 1, no. 3, pp. 158-159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. I. Chimowitz, M. J. Lynn, H. Howlett-Smith et al., “Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis,” New England Journal of Medicine, vol. 352, no. 13, pp. 1305–1397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Lylyk, J. F. Vila, C. Miranda et al., “Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis,” Neurological Research, vol. 27, no. 1, pp. S84–S88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. O. O. Zaidat, R. Klucznik, M. J. Alexander et al., “The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis,” Neurology, vol. 70, no. 17, pp. 1518–1524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Jiang, X. T. Xu, B. Du et al., “Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis,” Neurology, vol. 68, no. 6, pp. 420–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. I. Chimowitz, M. J. Lynn, and C. P. Derdeyn, “Stenting versus aggressive medical therapy for intracranial arterial stenosis,” The New England Journal of Medicine, vol. 365, no. 11, pp. 993–1003, 2011. View at Publisher · View at Google Scholar
  11. A. I. Qureshi, F. M. Al-Senani, S. Husain et al., “Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations,” Journal of Neuroimaging, vol. 22, no. 1, pp. 1–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. T. Higgins, D. G. Altman, and J. A. C. Sterne, “Assessing risk of bias in included studies,” in Cochrane Handbook for Systematic Reviews of Interventions, J. P. T. Higgins and and S. Green, Eds., The Cochrane Collaboration, London, United Kingdom, 2011. View at Google Scholar
  13. C. P. Derdeyn, M. I. Chimowitz, M. J. Lynn, and tal, “Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial,” The Lancet, vol. 383, no. 9914, pp. 333–341, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. O. O. Zaidat, B.-F. Fitzsimmons, B. K. Woodward et al., “Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial,” JAMA—Journal of the American Medical Association, vol. 313, no. 12, pp. 1240–1248, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Compter, H. B. van der Worp, W. J. Schonewille et al., “Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial,” The Lancet Neurology, vol. 14, no. 6, pp. 606–614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Abou-Chebl and H. Steinmetz, “Critique of 'stenting versus aggressive medical therapy for intracranial arterial stenosis' by Chimowitz et al. in the New England Journal of Medicine,” Stroke, vol. 43, no. 2, pp. 616–620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Yue, Q. Yin, G. Xi et al., “Comparison of BMSs with SES for symptomatic intracranial disease of the middle cerebral artery stenosis,” CardioVascular and Interventional Radiology, vol. 34, no. 1, pp. 54–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. W.-J. Jiang, E. Cheng-Ching, A. Abou-Chebl et al., “Multicenter analysis of stenting in symptomatic intracranial atherosclerosis,” Neurosurgery, vol. 70, no. 1, pp. 25–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Rohde, J. Seckinger, S. Hähnel, P. A. Ringleb, M. Bendszus, and M. Hartmann, “Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis—results of a single center study with 100 consecutive patients,” International Journal of Stroke, vol. 8, no. 2, pp. 87–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Miao, L. Song, D. S. Liebeskind et al., “Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS,” Journal of NeuroInterventional Surgery, vol. 7, no. 5, pp. 331–335, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. T.-X. Li, B.-L. Gao, D.-Y. Cai et al., “Wingspan stenting for severe symptomatic intracranial atherosclerotic stenosis in 433 patients treated at a single medical center,” PLoS ONE, vol. 10, no. 9, Article ID e0139377, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Miao, Y. Zhang, J. Shuai et al., “Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China,” Stroke, vol. 46, no. 10, pp. 2822–2829, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Gao, D. Wang, Z. Zhao et al., “Multicenter prospective trial of stent placement in patients with symptomatic high-grade intracranial stenosis,” American Journal of Neuroradiology, vol. 37, no. 7, pp. 1275–1280, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Alexander, P. M. Meyers, J. D. English et al., “Symptom differences and pretreatment asymptomatic interval affect outcomes of stenting for intracranial atherosclerotic disease,” American Journal of Neuroradiology, vol. 35, no. 6, pp. 1157–1162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. D. Alexander, D. L. Cooke, P. M. Meyers et al., “Lesion stability characteristics outperform degree of stenosis in predicting outcomes following stenting for symptomatic intracranial atherosclerosis,” Journal of NeuroInterventional Surgery, vol. 8, no. 1, pp. 19–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. M. P. Marks, “Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?” Stroke, vol. 43, no. 2, pp. 580–584, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. U. Farooq, F. Al-Ali, J. Min, and P. B. Gorelick, “Reviving intracranial angioplasty and stenting 'SAMMPRIS and beyond',” Frontiers in Neurology, vol. 5, article 101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Vajda, E. Schmid, T. Güthe et al., “The modified bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the enterprise stent,” Neurosurgery, vol. 70, no. 1, pp. 91–101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Feng, G. Duan, P. Zhang et al., “Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients,” BMC Neurology, vol. 15, no. 1, article 187, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. K. W. Muir and I. M. Macrae, “Neuroimaging as a selection tool and endpoint in clinical and pre-clinical trials,” Translational Stroke Research, vol. 7, no. 5, pp. 368–377, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Z. Imam, A. D’Souza, R. A. Malik, and A. Shuaib, “Secondary stroke prevention: improving diagnosis and management with newer technologies,” Translational Stroke Research, vol. 7, no. 6, pp. 458–477, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. F. K. Hui, X. Zhu, S. E. Jones et al., “Early experience in high-resolution MRI for large vessel occlusions,” Journal of NeuroInterventional Surgery, vol. 7, no. 7, pp. 509–516, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. X.-J. Zhu, W. Wang, B. Du et al., “Wall imaging for unilateral intracranial vertebral artery hypoplasia with three-dimensional high-isotropic resolution magnetic resonance images,” Chinese Medical Journal, vol. 128, no. 12, pp. 1601–1606, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. X.-J. Zhu, W.-J. Jiang, L. Liu, L.-B. Hu, W. Wang, and Z.-J. Liu, “Plaques of nonstenotic basilar arteries with isolated pontine infarction on three-dimensional high isotropic resolution magnetic resonance imaging,” Chinese Medical Journal, vol. 128, no. 11, pp. 1433–1437, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Zhu, L. Liu, X. He et al., “Wall thickening pattern in atherosclerotic basilar artery stenosis,” Neurological Sciences, vol. 37, no. 2, pp. 269–276, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. O. A. Berkhemer, P. S. Fransen, D. Beumer et al., “A randomized trial of intraarterial treatment for acute ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 1, pp. 11–20, 2015. View at Google Scholar
  37. B. C. Campbell, P. J. Mitchell, T. J. Kleinig et al., “Endovascular therapy for ischemic stroke with perfusion-imaging selection,” The New England Journal of Medicine, vol. 372, pp. 1009–1018, 2015. View at Publisher · View at Google Scholar
  38. M. Goyal, A. M. Demchuk, B. K. Menon et al., “Randomized assessment of rapid endovascular treatment of ischemic stroke,” The New England Journal of Medicine, vol. 372, pp. 1019–1030, 2015. View at Publisher · View at Google Scholar
  39. S. G. Ellis, D. J. Kereiakes, D. C. Metzger et al., “Everolimus-eluting bioresorbable scaffolds for coronary artery disease,” The New England Journal of Medicine, vol. 373, no. 20, pp. 1905–1915, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. T. G. Jovin, A. Chamorro, E. Cobo et al., “Thrombectomy within 8 hours after symptom onset in ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 24, pp. 2296–2306, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Ribo, A. Flores, M. Rubiera et al., “Extending the time window for endovascular procedures according to collateral pial circulation,” Stroke, vol. 42, no. 12, pp. 3465–3469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Henninger and M. Fisher, “Extending the time window for endovascular and pharmacological reperfusion,” Translational Stroke Research, vol. 7, no. 4, pp. 284–293, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Tsivgoulis, A. Safouris, C. Krogias, A. S. Arthur, and A. V. Alexandrov, “Endovascular reperfusion therapies for acute ischemic stroke: Dissecting the evidence,” Expert Review of Neurotherapeutics, vol. 16, no. 5, pp. 527–534, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. J.-H. Baek, B. M. Kim, D. J. Kim, J. H. Heo, H. S. Nam, and J. Yoo, “Stenting as a rescue treatment after failure of mechanical thrombectomy for anterior circulation large artery occlusion,” Stroke, vol. 47, no. 9, pp. 2360–2363, 2016. View at Publisher · View at Google Scholar · View at Scopus